Literature DB >> 24509868

[COPD and heart disease].

H Watz1, M Arzt.   

Abstract

Cardiovascular diseases are highly prevalent in patients with chronic obstructive pulmonary disease (COPD). Approximately one out of three patients with COPD dies of cardiovascular disease. Overlap syndrome (COPD and obstructive sleep apnea), pulmonary hypertension and lung hyperinflation have a further impact on cardiovascular function in patients with COPD.

Entities:  

Mesh：

Year:  2014        PMID： 24509868     DOI： 10.1007/s00059-014-4059-4

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  51 in total

1.  Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective.

Authors:  Omar A Minai; Ari Chaouat; Serge Adnot
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

Review 2.  Systemic manifestations of COPD.

Authors:  Yvonne Nussbaumer-Ochsner; Klaus F Rabe
Journal:  Chest       Date:  2011-01       Impact factor: 9.410

3.  Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease.

Authors:  J Butler; F Schrijen; A Henriquez; J M Polu; R K Albert
Journal:  Am Rev Respir Dis       Date:  1988-08

4.  Pulmonary hypertension in COPD: results from the ASPIRE registry.

Authors:  Judith Hurdman; Robin Condliffe; Charlie A Elliot; Andrew Swift; Smitha Rajaram; Christine Davies; Catherine Hill; Neil Hamilton; Iain J Armstrong; Catherine Billings; Lauren Pollard; Jim M Wild; Allan Lawrie; Rod Lawson; Ian Sabroe; David G Kiely
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671

Review 5.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

6.  Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation.

Authors:  Henrik Watz; Benjamin Waschki; Trhorsten Meyer; Gunther Kretschmar; Anne Kirsten; Martin Claussen; Helgo Magnussen
Journal:  Chest       Date:  2010-02-26       Impact factor: 9.410

7.  Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics.

Authors:  S E Sheifer; S S Rathore; B J Gersh; K P Weinfurt; W J Oetgen; J A Breall; K A Schulman
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

8.  Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.

Authors:  J Travers; P Laveneziana; K A Webb; S Kesten; D E O'Donnell
Journal:  Respir Med       Date:  2007-05-01       Impact factor: 3.415

9.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

10.  Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

Authors:  Henrik Watz; Benjamin Waschki; Corinna Boehme; Martin Claussen; Thorsten Meyer; Helgo Magnussen
Journal:  Am J Respir Crit Care Med       Date:  2007-11-29       Impact factor: 21.405
View more
  1 in total

1.  The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk.

Authors:  Denitza P Blagev; Dave S Collingridge; Susan Rea; Benjamin D Horne; Valerie G Press; Matthew M Churpek; Kyle A Carey; Richard A Mularski; Siyang Zeng; Mehrdad Arjomandi
Journal:  Front Med (Lausanne)       Date:  2018-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.